In summary, in tumours derived from GBM, breast and lung cancers, regardless of the cellular origin or mutations carried, VDAC1 depletion led to similar metabolic reprogramming, including reversal of the cancer cell’s metabolic adaptation as controlled by the AMPK and mTOR signalling pathways. This evidence concerns the gene VDAC1 and lung carcinoma.